The ASX-listed company reported record revenue and earnings for the 2026 financial year, as higher manufacturing volumes and a growing international customer base pushed the company further into the ranks of global regulated-medicines suppliers. …
Latest Video
New Stories
-
Six Australian infectious disease ventures share $10.48 million in Biointelect funding round
August 31, 2026 - - Latest News -
BLS posts record earnings as overseas expansion accelerates
August 31, 2026 - - Latest News -
Private hospitals sustain 230,000 jobs despite $756 million loss
August 31, 2026 - - Other Health -
Alterity secures option underwriting as it prepares for pivotal MSA trial
August 31, 2026 - - Australian Biotech -
Avecho resumes pivotal insomnia trial recruitment after positive interim review
August 31, 2026 - - Australian Biotech -
Tetratherix sends first commercial polymer shipment to United States
August 31, 2026 - - Australian Biotech -
September agenda puts cancer drugs, RSV prevention and ADHD access in focus
August 31, 2026 - - Latest News